New Migraine Drugs Target Triptan Contraindication Population
November 5th 2020The current acute treatments for migraines have shown efficacy and safety, however, approximately one-third of people do not respond, cannot use these options due to contraindications, or report dissatisfaction in therapy.
Read More
Short-Term and Long-Term Impact of COVID-19 on Community Pharmacy
July 8th 2020Whether it be delivery options, remote pharmacy, increasing roles for pharmacists and technicians, or fluctuating patient volume, the impact of COVID-19 can be felt in community pharmacies across the United States.
Read More